Shaw Allan

SEC source: 0001626850-26-000002 · form4-10052026_091056.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2036-09-30

F1 · derivative.exercise_date: Beginning August 19, 2026, 1/12th of the shares subject to the option vest in equal monthly installments over a one year period, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc.

SEC source: 0001626850-26-000001 · form4-08212026_100848.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2036-08-18

F1 · derivative.exercise_date: 1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant, provided that the option will in any case be fully vested on the date of the 2027 annual meeting of stockholders of CalciMedica, Inc.

SEC source: 0001415889-25-018300 · form4-06262025_100625.xml · derivative · entry 4

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2035-06-23

F5 · derivative.exercise_date: 1/12th of the shares subject to the option vest in equal monthly installments over a one year period following June 24, 2025, provided that the shares will in any case be fully vested on the date of Company's 2026 annual meeting of stockholders.

SEC source: 0001415889-25-018300 · form4-06262025_100625.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,250

Underlying: Common Stock · 26,250 shares

Expires 2035-04-22

F1 · date: The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.

F4 · derivative.exercise_date: 1/9th of the shares subject to the option vest in equal monthly installments over a one year period following April 1, 2025.

SEC source: 0001415889-25-018300 · form4-06262025_100625.xml · derivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,594

Underlying: Common Stock · 8,594 shares

Expires 2035-04-22

F1 · date: The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.

F3 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001415889-25-018300 · form4-06262025_100625.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2035-04-22

F1 · date: The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.

F2 · derivative.exercise_date: 1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 26, 2025.

SEC source: 0001415889-24-022507 · form4-08282024_110830.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-08-26

F1 · derivative.exercise_date: 1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 28, 2024.

SEC source: 0001415889-24-011352 · form4-04232024_010404.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-03-27

F1 · derivative.exercise_date: 1/12th of the shares subject to the option vest in equal monthly installments over a one year period following the date of grant.

SEC source: 0001209191-23-040096 · doc4.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-05-07

F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest in equal monthly installments over a three year period following the date of grant.

SEC source: 0001209191-23-020683 · doc4.xml · derivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 744

Underlying: Common Stock · 744 shares

Expires 2032-11-21

F4 · price: Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock.

F5 · price: Received in exchange for a stock option to acquire 25,846 shares of common stock of CalciMedica pursuant to the Merger Agreement.

F3 · derivative.exercise_date: Beginning on November 22, 2022, the shares subject to the option vest in a series of twelve (12) successive equal monthly installments.

SEC source: 0001209191-23-020683 · doc4.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,880

Underlying: Common Stock · 2,880 shares

Expires 2031-12-30

F2 · price: Received in exchange for a stock option to acquire 100,000 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.

F1 · derivative.exercise_date: Beginning on October 12, 2021, the shares subject to the option vest in a series of thirty-six (36) successive equal monthly installments.

SEC source: 0001213900-22-050550 · ownership.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,284

Underlying: Common Stock · 29,636 shares

Expires 2030-01-14

SEC source: 0001213900-22-050550 · ownership.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The Common Stock reported herein were sold by the reporting person at a high price of $4.02, a low price of $3.91 and an average price of $3.94 per share of Common Stock. Upon request, the reporting person will provide details of each sale.

SEC source: 0001213900-22-050550 · ownership.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,636

SEC source: 0001213900-22-029991 · ownership.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,575

Underlying: Common Stock, par value $0.00001 per share · 4,655 shares

Expires 2032-05-04

F1 · derivative.exercise_date: Stock options (the "Options") were granted to Mr. Shaw on May 4, 2022. The Options vest and become exercisable as follows: (i) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023; and (iii) the remaining 389 Options vest on March 31, 2023.

SEC source: 0001123292-18-001045 · edgar.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires not disclosed

F1 · derivative.exercise_date: One twelfth (1/12th) of the total number of shares underlying the option vest and become exercisable on the 26th of each month following October 26, 2018, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2018 Equity Incentive Plan) on the relevant vesting dates.

F2 · derivative.expiration_date: The option expires on the earlier of (a) October 26, 2025 and (b) the six (6) month anniversary of the date the reporting person ceases to be a Service Provider.

SEC source: 0001123292-18-000997 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,389

F4 · shares: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.

F5 · price: The price reported for the securities is the market value on the business day immediately before September 15, 2018.

F3 · balance_after: The number of shares beneficially owned following the reported transaction has been adjusted to reflect the Reverse Split (with fractional shares rounded up to the next whole number).

SEC source: 0001123292-18-000997 · edgar.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,432

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On September 10, 2018, VIVUS, Inc. effected a 1-for-10 reverse stock split (the "Reverse Split"). Accordingly, 1,389 shares of common stock on a pre-Reverse Split basis were adjusted to 139 shares following the Reverse Split (with fractional shares rounded up to the next whole number). The shares of common stock relate to the previously disclosed restricted stock units that vested on September 15, 2018 and released on October 1, 2018.

F2 · price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · balance_after: The number of shares beneficially owned following the reported transaction has been adjusted to reflect the Reverse Split (with fractional shares rounded up to the next whole number).

SEC source: 0001123292-18-000962 · edgar.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139

Underlying: Common Stock · 139 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On September 10, 2018, VIVUS, Inc. effected a 1-for-10 reverse stock split (the "Reverse Split"). Accordingly, 1,389 shares of common stock on a pre-Reverse Split basis was adjusted to 139 shares following the Reverse Split (with fractional shares rounded up to the next whole number). The shares of common stock will be released to the reporting person on a later date.

F2 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F1 · shares: On September 10, 2018, VIVUS, Inc. effected a 1-for-10 reverse stock split (the "Reverse Split"). Accordingly, 1,389 shares of common stock on a pre-Reverse Split basis was adjusted to 139 shares following the Reverse Split (with fractional shares rounded up to the next whole number). The shares of common stock will be released to the reporting person on a later date.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016 and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016 and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates

F1 · derivative.underlying_shares: On September 10, 2018, VIVUS, Inc. effected a 1-for-10 reverse stock split (the "Reverse Split"). Accordingly, 1,389 shares of common stock on a pre-Reverse Split basis was adjusted to 139 shares following the Reverse Split (with fractional shares rounded up to the next whole number). The shares of common stock will be released to the reporting person on a later date.

F1 · balance_after: On September 10, 2018, VIVUS, Inc. effected a 1-for-10 reverse stock split (the "Reverse Split"). Accordingly, 1,389 shares of common stock on a pre-Reverse Split basis was adjusted to 139 shares following the Reverse Split (with fractional shares rounded up to the next whole number). The shares of common stock will be released to the reporting person on a later date.

SEC source: 0001123292-18-000935 · edgar.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,778

Underlying: Common Stock · 1,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016 and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016 and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

SEC source: 0001123292-18-000935 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,928

F2 · shares: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.

SEC source: 0001123292-18-000935 · edgar.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,366

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

SEC source: 0001123292-18-000863 · edgar.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,167

Underlying: Common Stock · 1,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016 and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016 and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

SEC source: 0001123292-18-000863 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,977

F2 · shares: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.

SEC source: 0001123292-18-000863 · edgar.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,416

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

SEC source: 0001123292-18-000823 · edgar.xml · derivative · entry 4

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

F4 · derivative.expiration_date: The option expires on the earlier of (a) June 15, 2025 or (b) the six month anniversary of the date the reporting person ceases to be a Service Provider (as defined in the Issuer's 2010 Equity Incentive Plan).

SEC source: 0001123292-18-000823 · edgar.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,556

Underlying: Common Stock · 1,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016 and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016 and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

SEC source: 0001123292-18-000823 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,027

F2 · shares: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.

SEC source: 0001123292-18-000823 · edgar.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,465

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

SEC source: 0001123292-18-000705 · edgar.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director · Consultant

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,945

Underlying: Common Stock · 1,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

SEC source: 0001123292-18-000705 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director · Consultant

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,076

F2 · kind: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.

SEC source: 0001123292-18-000705 · edgar.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director · Consultant

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,514

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

SEC source: 0001123292-18-000640 · edgar.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director · Consultant

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,334

Underlying: Common Stock · 1,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

SEC source: 0001123292-18-000640 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director · Consultant

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,125

F2 · kind: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.

SEC source: 0001123292-18-000640 · edgar.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director · Consultant

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,563

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

SEC source: 0001123292-18-000546 · edgar.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director · Consultant

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,723

Underlying: Common Stock · 1,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

SEC source: 0001123292-18-000546 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director · Consultant

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,174

F2 · kind: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.

SEC source: 0001123292-18-000546 · edgar.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director · Consultant

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,612

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

SEC source: 0001123292-18-000539 · edgar.xml · derivative · entry 1

Shaw Allan · CIK 0001626850 · Director · Consultant

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires not disclosed

F1 · derivative.exercise_date: 50,000 shares subject to the option shall be vested and exercisable on the date of grant; 50,000 shares subject to the option shall vest and become exercisable on June 30, 2018; 100,000 shares subject to the option shall vest and become exercisable on December 31, 2018; and 100,000 shares subject to the option shall vest and become exercisable on June 30, 2019, subject to the reporting person continuing to provide services on the relevant vesting dates pursuant to that certain Consulting Agreement, effective February 1, 2018, between the Issuer and the reporting person.

F2 · derivative.expiration_date: The option expires on the earlier of (a) March 9, 2025 and (b) the six month anniversary of the date the reporting person ceases to be a Service Provider (as defined in the Issuer's 2010 Equity Incentive Plan).

SEC source: 0001123292-18-000364 · edgar.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,112

Underlying: Common Stock · 1,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

SEC source: 0001123292-18-000364 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,223

F2 · kind: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.

SEC source: 0001123292-18-000364 · edgar.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

SEC source: 0001123292-18-000157 · edgar.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,501

Underlying: Common Stock · 1,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

SEC source: 0001123292-18-000157 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,272

F2 · kind: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.

SEC source: 0001123292-18-000157 · edgar.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,752

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

SEC source: 0001123292-17-001785 · edgar.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,890

Underlying: Common Stock · 1,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

SEC source: 0001123292-17-001785 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,363

F2 · kind: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.

SEC source: 0001123292-17-001785 · edgar.xml · nonDerivative · entry 1

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,844

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

SEC source: 0001123292-17-001722 · edgar.xml · derivative · entry 3

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,279

Underlying: Common Stock · 1,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units converted into VIVUS, Inc. common stock on a 1-for-1 basis upon vesting.

F3 · derivative.exercise_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

F3 · derivative.expiration_date: The restricted stock units vest according to the following schedule: 8/36ths of the total restricted stock units originally granted vested on May 15, 2016, and an additional 1/36th of the total restricted stock units originally granted vest on the 15th of each month thereafter, subject to the individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates.

SEC source: 0001123292-17-001722 · edgar.xml · nonDerivative · entry 2

Shaw Allan · CIK 0001626850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,455

F2 · kind: The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability.